Activation of cyclin-dependent kinase 5 mediates orofacial mechanical hyperalgesia

Michaela Prochazkova, Anita Terse, Niranjana D Amin

  • 1Functional Genomics Section, Laboratory of Cell and Developmental Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA. ak40m@nih.gov.

Molecular Pain
|December 24, 2013
PubMed
Abstract

Insights

Cyclin-dependent kinase 5 (Cdk5) plays a key role in orofacial pain. Increased Cdk5 activity heightened pain responses, while reduced activity decreased them, suggesting Cdk5 as a potential pain relief target.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pain Research

Background:

  • Cyclin-dependent kinase 5 (Cdk5) is crucial for neuronal development and function.
  • Cdk5 activity is implicated in neurodegenerative disorders and nociceptive signaling.
  • Cdk5 and its activator p35 are upregulated in inflamed nociceptive neurons.

Purpose of the Study:

  • To investigate the role of Cdk5 in orofacial pain.
  • To characterize Cdk5's involvement in mechanical hyperalgesia within the trigeminal region.

Main Methods:

  • Utilized transgenic mice with altered Cdk5 activity (overexpressing or lacking p35).
  • Assessed behavioral responses to mechanical stimulation in the trigeminal area using an orofacial stimulation test.
  • Measured reward licking events and licking time as indicators of pain perception.

Main Results:

  • Mice with increased Cdk5 activity showed aversion to mechanical stimulation, with decreased licking events and time.
  • Higher mechanical intensity led to a significant reduction in licking events in these mice.
  • Mice with reduced Cdk5 activity exhibited mechanical hypoalgesia.

Conclusions:

  • Cdk5 is demonstrated to play a significant role in orofacial mechanical nociception.
  • Modulating Cdk5 activity in primary sensory neurons presents a potential therapeutic strategy.
  • Cdk5 inhibition could lead to novel analgesics for orofacial pain conditions.